
Aurelius exits Transform Hospital Group to Y1 Capital
Aurelius has sold the operating company of cosmetic surgery group Transform Hospital Group (THG) to Y1 Capital.
Y1 owns a portfolio of healthcare services businesses in the UK and Europe, including cosmetic surgery and hair transplant chain Signature Medical.
The buying GP's CEO Tony Veverka is the former CEO of THG. Y1 is undertaking a roll-up in the sector with a view to IPO in the Nordic Growth markets, according to its website.
Aurelius formed THG in 2015 through the merger of Transform and The Hospital Group. The company offers cosmetic surgery including weight loss treatment via 11 outpatient clinics and two hospitals in the UK.
The GP will continue to own The Pines hospital, located in Manchester.
The group had revenues of GBP 48m in 2021, saying in its most recent financial reports that its core markets had returned to pre-pandemic demand.
Aurelius said that the deal was completed via a competitive sales process.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds